张国淳，廖宁
广东省人民医院
广东省医学科学院
参考文献
JAMESON J L, LONGO D L. Precision medicine—personalized. problematic, and promising. N Engl J Med. ;372(23):2229-2234.
ZURRIDA S, VERONESI U. Milestones in breast cancer treatment. Breast J. ;21(1):3-12.
MAGNONI F, ACCARDO G, ROSSI E, et al. Anatomy is not enough: The crucial role of biology and genetics in AJCC eighth edition of the TNM classification for breast cancer. Ann Transl Med. ;7(1S):S34.
GOLDHIRSCH A, WOOD W C, COATES A S, et al. Strategies for subtypes—dealing with the diversity of breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer . Ann Oncol. ;22(8):1736-1747.
KOHLER B A, SHERMAN R L, HOWLADER N, et al. Annual report to the nation on the status of cancer. 1975-;featuring incidence of breast cancer subtypes by race/ethnicity. poverty. and state. J Natl Cancer Inst. ;107(6):djv048.
PAIK S, SHAK S, TANG G, et al. A multigene assay to predict recurrence of Tamoxifen-treated. node-negative breast cancer. N Engl J Med. ;351(27):2817-2826.
CARDOSO F, van"t VEER L J, BOGAERTS J, et al. 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med. ;375(8):717-729.
FILIPITS M, RUDAS M, JAKESZ R, et al. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res. ;17(18):6012-6020.
ZHANG Y, SCHNABEL C A, SCHROEDER B E, et al. Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early-and late-distant recurrence. Clin Cancer Res. ;19(15):4196-4205.
LAENKHOLM A V, JENSEN M B, ERIKSEN J O, et al. PAM50 risk of recurrence score predicts 10-year distant recurrence in a comprehensive Danish cohort of postmenopausal women allocated to 5 years of endocrine therapy for hormone receptor-positive early breast cancer. J Clin Oncol. ;36(8):735-740.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in Breast Cancer.V1..
AMIN M B, EDGE S B, GREENE F L, et al. AJCC (American Joint Committee on Cancer) Cancer Staging Manual (8th edition). Chicago: Springer International Publishing, .
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)乳腺癌临床诊疗指南(). 北京:人民卫生出版社. .
SPARANO J A, GRAY R J, MAKOWER D F, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. ;379(2):111-121.
HOCHHEISER L, HORNBERGER J, TURNER M, et al. Multi-gene assays: Effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer. J Comp Eff Res. ;8(5):289-304.
通讯作者：廖宁, drliaoning@
原文参见：循证医学. ;19(3):133-135.
